Skip to main content
GlaxoSmithKline PLC logo

GlaxoSmithKline PLC — Investor Relations & Filings

Ticker · GSK ISIN · GB00BN7SWP63 LEI · 5493000HZTVUYLO1D793 IL Manufacturing
Filings indexed 7,016 across all filing types
Latest filing 2025-11-14 Transaction in Own Shar…
Country GB United Kingdom
Listing IL GSK

About GlaxoSmithKline PLC

https://www.gsk.com/en-gb/

GSK plc is a global biopharmaceutical company that unites science, technology, and talent to research, develop, and manufacture medicines and vaccines. The company focuses on preventing and treating disease across four primary therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. Its portfolio consists of specialty medicines and vaccines aimed at addressing significant global health needs. GSK's strategy centers on leveraging its research and development capabilities to deliver new health solutions.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from GSK plc regarding the purchase of its own shares (a share buyback program). It provides specific details on the number of shares purchased, the price paid, and the trading venues used, which is characteristic of a 'Transaction in Own Shares' filing. It is not a report publication announcement, but rather the report of the transaction itself.
2025-11-14 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2025-11-13 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a standard regulatory notification regarding transactions in company shares by Persons Discharging Managerial Responsibilities (PDMRs). It explicitly lists the names, positions, and transaction details (acquisition of shares under a Share Reward Plan) for multiple executives at GSK plc. This format is the classic 'Director's Dealing' notification required by financial regulators (such as the FCA in the UK) to disclose insider transactions.
2025-11-13 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-11-13 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is a regulatory announcement from GSK plc regarding the purchase of its own shares (share buyback). It details the number of shares purchased, the price paid, and the venue of the transactions, which is characteristic of a 'Transaction in Own Shares' filing. It is not a report publication announcement, but rather the report of the transaction itself.
2025-11-13 English
BLOCK LISTING INTERIM REVIEW
Regulatory Filings
2025-11-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.